The pathogenic sequelae of BRCA1 mutation in human and mouse cells are mitigated by concomitant deletion of 53BP1, which binds histone H4 dimethylated at Lys20 (H4K20me2) to promote nonhomologous end joining, suggesting that a balance between BRCA1 and 53BP1 regulates DNA double strand-break (DSB) repair mechanism choice. Here we document that acetylation is a key determinant of this balance. TIP60 acetyltransferase deficiency reduced BRCA1 at DSB chromatin with commensurate increases in 53BP1, whereas HDAC inhibition yielded the opposite effect. TIP60-dependent H4 acetylation diminished 53BP1 binding to H4K20me2 in part through disruption of a salt bridge between H4K16 and Glu1551 in the 53BP1 Tudor domain. Moreover, TIP60 deficiency impaired homologous recombination and conferred sensitivity to PARP inhibition in a 53BP1dependent manner. These findings demonstrate that acetylation in cis to H4K20me2 regulates relative BRCA1 and 53BP1 DSB chromatin occupancy to direct DNA repair mechanism.
Dynamic modifications of large stretches of chromatin in cis to DNA DSBs regulate the modular and ordered assembly of repair proteins at sites of damaged DNA. Genetic evidence suggests that the balance between two such proteins, BRCA1 (breast cancer early onset 1) and 53BP1 (p53 binding protein 1, also known as TP53BP1), influences DNA end resection and is therefore a determinant of whether DSB repair ensues predominantly by either homologous recombination or nonhomologous end joining (NHEJ) [1] [2] [3] . An imbalance in this competition manifests in multiple pathophysiologic processes. BRCA1 is required for embryogenesis, with complete nullizygosity in mice resulting in lethality between embryonic day (E) 5.5 and E8.5. Hypomorphic mice with BRCA1 exon 11 deleted survive to adulthood in the context of p53 heterozygosity but show premature aging, cancer susceptibility and hypersensitivity to DNA-damaging agents 4 . Each of these phenotypes closely correlates with homologous recombination impairment and the resultant genomic instability from BRCA1 deficiency [1] [2] [3] [4] .
Conversely, mice harboring mutation in both BRCA1 and 53BP1 are viable through adulthood without increased cancer susceptibility. Doubly deficient BRCA1 −/− 53BP1 −/− cells have restored homologous recombination and genomic stability and are resistant to poly(ADPribose) polymerase inhibitors (PARPi). 53BP1 DSB localization and function in NHEJ requires its tandem Tudor repeats, which recognize H4K20me1 and H4K20me2 at DNA damage sites [5] [6] [7] . Mice expressing a 53BP1 Tudor domain-mutant protein that does not bind H4K20me2 still rescued BRCA1-null phenotypes 8 , indicating that 53BP1 DSB chromatin association blocks an essential aspect of homologous recombination in the absence of functional BRCA1 protein. This appears to be DSB end resection, which occurs at elevated levels in 53BP1-null cells 9 , enabling homologous recombination to occur in the context of BRCA1 mutation to maintain genomic stability 1, 2 . These findings implicate control of end resection as the critical step that is regulated by the competition between BRCA1 and 53BP1 at DSB chromatin.
Given these observations, the identification of molecular determinants uniquely affecting BRCA1 and 53BP1 occupancy at DSBs would be a fundamentally important finding that is relevant to genome integrity, carcinogenesis and, potentially, cancer therapy. Paradoxically, 53BP1 and BRCA1 DSB chromatin association are both dependent on a phosphorylation-ubiquitylation cascade involving γ-H2AX, MDC1, RNF8 and RNF168 (refs. [10] [11] [12] [13] [14] . RNF8 recognizes phosphorylated MDC1 to initiate DSB ubiquitylation, which is continued by RNF168 to produce both degradative and nondegradative ubiquitin chains. BRCA1 is targeted to DSBs in part by an interaction with the ubiquitin-binding protein RAP80, which recognizes RNF8-and RNF168-dependent Lys63-linked ubiquitin [15] [16] [17] . BRCA1 also has additional modes of DSB recognition, as it is a component of multiple protein complexes that are distinct from the RAP80 complex, most of which do not directly rely on ubiquitin recognition for DSB localization [18] [19] [20] .
Concurrently, 53BP1 DSB localization requires RNF8 and RNF168 E3 ubiquitin ligase activities despite the lack of a clear ubiquitinbinding domain in 53BP1 or in any 53BP1-associated protein.
Elevated RNF168 activity at DSB chromatin results in increased a r t i c l e s 53BP1 and BRCA1 DSB localization, demonstrating that localization of both proteins is positively correlated with DSB ubiquitin levels 21, 22 . 53BP1 DSB localization also requires RNF8-and RNF168-mediated degradation of chromatin proteins that compete with 53BP1 for binding to H4K20me2 (refs. 23,24) . The requirement for DSB ubiquitylation was obviated by short interfering RNA (siRNA)-mediated knockdown of H4K20me2-binding factors, enabling 53BP1 focus formation in RNF8-and RNF168-mutant cells 24 . These reports suggest that ubiquitylation modulates accessibility for H4K20me2 as a limiting component of 53BP1 DSB accumulation and that there may be other factors that regulate this accessibility. Therefore, although DSB ubiquitin and 53BP1 levels closely parallel each other under most circumstances, they may not do so under scenarios that result in enhanced 53BP1 access for methylated H4K20.
Here we set out to identify factors that affect the balance between BRCA1 and 53BP1 at DSBs. We document that histone H4 acetylation is a crucial determinant of the relative DSB chromatin occupancy and repair activities of BRCA1 and 53BP1. These findings reveal a previously unappreciated mechanism that sequential histone-tail modifications direct DNA repair mechanism and are a key determinant of chemotherapeutic response.
RESULTS

Acetylation differentially regulates BRCA1 and 53BP1 at DSBs
Acetylation and methylation are chemically exclusive modifications of the ε-amino group of lysine side chains. Because 53BP1 relies on its tandem Tudor domains (53BP1-Tudor) to form DNA damage foci by recognizing H4K20me2 (refs. 5,7,25) , we postulated that acetylation would negatively affect 53BP1 chromatin association, thereby controlling the relative occupancy of BRCA1 and 53BP1 at DSBs. The acetyltransferase TIP60 could contribute to this balance given its known involvement in the early stages of the DSB response as part of the chromatin-remodeling NuA4 complex [26] [27] [28] [29] . To determine whether TIP60 influences BRCA1 accumulation at DSBs, we transfected U2OS cells with siRNAs to either TIP60 or RVB1, each of which encodes a component of the NuA4 complex that is required for TIP60 acetyltransferase activity, and examined the kinetics of BRCA1 accumulation at ionizing radiation-induced foci (IRIF). We found strong decreases in BRCA1 foci formation at all time points after knockdown of either gene (Supplementary Fig. 1a -c) and after expression of an acetyltransferase-inactive TIP60 mutant ( Supplementary  Fig. 1e ). BRCA1 IRIF were partially restored by treatment with trichostatin A (TSA), a class I and II HDAC inhibitor (HDACi), but not with nicotinamide ( Supplementary Fig. 1d ). In contrast, TSA and several other class I and II HDACi strongly reduced 53BP1 IRIF ( Supplementary Fig. 1f,g) .
To assay how acetylation regulates the balance between BRCA1 and 53BP1 DSB localization at a single locus in a genome, we monitored their localization in a DSB reporter system that uses an mCherry-LacI-FokI nuclease fusion protein to create DSBs within a single genomic locus in U2OS cells (U2OS-DSB reporter) 30 . We equipped this cell line with stable expression of the mCherry-LacI-FokI nuclease fused to a destabilization domain and a modified estradiol receptor. This enabled inducible nuclease expression after administration of the small molecules Shield-1 ligand and 4-hydroxytamoxifen (4-OHT) ( Fig. 1a ). Knockdown of TIP60 or RVB1 substantially reduced BRCA1 localization to mCherry-LacI-FokI-induced DSBs, whereas 53BP1 showed a more than two-fold increase in DSB accumulation ( Fig. 1b and Supplementary Fig. 1h ), revealing concordance between chromatin responses to ionizing radiation and nucleaseinduced DSBs.
Chromatin immunoprecipitation (ChIP) for 53BP1 and BRCA1 at the U2OS-DSB-reporter locus produced results consistent with imaging studies, showing two-to four-fold changes in BRCA1 and a b
c d e f npg a r t i c l e s 53BP1 DSB levels depending on acetylation status. Administration of TSA resulted in elevated H4 acetylation (H4ac) and a nearly four-fold increase in BRCA1 occupancy coupled with diminished 53BP1 association, whereas knockdown of TIP60 or RVB1 produced the opposite effect ( Fig. 1c-f ). Moreover, knockdown of both HDAC1 and HDAC2 resulted in reduced 53BP1 and a corresponding increase in BRCA1 at mCherry-LacI-FokI-induced DSBs (Supplementary Fig. 1i-k) .
Knockdown of the genes encoding four different members of the NuA4 histone acetyltransferase complex (TIP60, RVB1, TRRAP and p400) increased 53BP1 DSB localization despite modestly reducing DSB-associated ubiquitin foci (Supplementary Figs. 2a-c and 3) . Ubiquitin IRIF were substantially more reduced after RNF168 knockdown as compared to TIP60 knockdown, and this level of reduction in ubiquitin indeed abrogated 53BP1 foci formation ( Supplementary  Figs. 2a-c and 3a) . Notably, 53BP1 IRIF remained undetectable after knockdown of either TIP60 or RVB1 in RNF168-mutated RIDDLE cells ( Supplementary Fig. 2d ). These findings reveal a strict requirement for RNF168 even in the context of TIP60 deficiency, indicating that RNF168-dependent ubiquitylation cannot be circumvented by decreased TIP60 acetylation.
BRCA1 and 53BP1 occupy distinct chromatin domains
To explore the relationship between acetylation and competition between BRCA1 and 53BP1 at defined endogenous genomic sites, we developed a new system to quantify the accumulation of DSB response proteins along large stretches of subtelomeric chromatin after expression of the telomere-specific binding protein TRF1 fused to FokI. TRF1-FokI localized exclusively to telomeres and produced a focal accumulation of γ-H2AX, 53BP1 and BRCA1 that spread at least several hundred kilobases into subtelomeric chromatin ( Fig. 2a,b and Supplementary   Fig. 4a-d ). In accordance with previous results, we found a divergent response of BRCA1 and 53BP1 at subtelomeric chromatin after TSA treatment in TRF1-FokI-expressing cells (Fig. 2b) . These results confirm the data from the U2OS-DSB reporter system and IRIF results and suggest the finding that acetylation exerts opposing regulation of the association of BRCA1 and 53BP1 with DSB chromatin is generally relevant to DSB responses at endogenous locations.
These findings demonstrate that a balance of acetyltransferase and deacetylase activities strongly influences BRCA1 and 53BP1 DSB chromatin levels. Furthermore, the ratios of BRCA1 to 53BP1 at DSB chromatin correlated with the degree of H4ac. High levels of H4ac are present at the 5′ end of actively transcribed genes. We therefore postulated that transcription-induced H4ac, in combination with DNA damage-induced H4ac, would result in elevated levels of BRCA1 and reduced levels of 53BP1 at DSB chromatin. Moreover, this balance would be altered by TIP60 knockdown, leading to elevated 53BP1 levels in a DSB chromatin territory in which BRCA1 normally predominates.
To test this hypothesis, we monitored the associations of BRCA1 and 53BP1 with endogenous regions on chromosome 16p that were predicted to show hyperacetylation and RNA polymerase II (RNA PolII) association by the ENCODE database ( Fig. 2c) 31 . This region showed strong induction of γ-H2AX and increased H4K16 acetylation (H4K16ac) after TRF1-FokI expression ( Supplementary Fig. 4d,e ), as was originally noted at yeast DSBs 32 . TIP60 knockdown consistently increased 53BP1 association and decreased both H4ac and BRCA1 association at all four loci ( Fig. 2d) , revealing that TIP60-dependent acetylation limits 53BP1 levels at chromatin territories in cis to DSBs that are predominantly occupied by BRCA1.
To specifically address the role of transcription-dependent acetylation, we induced DSBs at either transcriptionally silent or active npg a r t i c l e s chromatin. mCherry-LacI-FokI DSBs can be induced in the reporter system in either transcriptionally silent or active environments through a doxycycline-regulated promoter that is downstream of tetracycline-regulated elements 30, 33 (Fig. 2e) . The presence of active transcription before DSB induction resulted in elevated H4ac and BRCA1 levels with a commensurate decline in 53BP1 levels at each of four different positions in cis to the DSB site ( Fig. 2f) . Collectively, these data demonstrate that a combination of DNA damage-and transcription-inducible acetylation states affect the relative levels of BRCA1 and 53BP1 at DSB chromatin.
H4K16 acetylation reduces 53BP1 binding to H4K20me2
Given that dimethylation and acetylation are mutually exclusive modifications on the ε-amino group of a particular lysine residue, we initially postulated that H4K20me2 levels would be decreased after TSA treatment, accounting for the absence of 53BP1 foci after HDACi. However, 5 h of TSA treatment did not affect total H4K20me2 as measured by immunoblotting ( Fig. 3a) . This result is consistent with the known stability of H4K20me2, which is thought to be present at approximately 70-90% of chromatin-associated H4 molecules 34 .
These observations suggest that acetylation at residues other than H4K20 may diminish the access of 53BP1 to H4K20me2. In this regard, histone H4 is acetylated at Lys16 residues, a modification that is reported to be present in nearly 20% of the H4 N-terminal tails that include H4K20me2 (ref. 34) . To test the hypothesis that acetylation in cis to H4K20me2 could affect the 53BP1 interaction, we incubated increasing amounts of 53BP1-Tudor with biotinylated peptides encompassing residues 12-25 of histone H4 dimethylated at Lys20 and unmodified at every other residue or dimethylated at Lys20 and acetylated at Lys16 (Fig. 3b) a r t i c l e s acetylated peptide at all concentrations tested (Fig. 3b) . Meanwhile, TIP60 depletion resulted in a reduction in H4K16ac on chromatin adjacent to LacI-FokI-generated DSBs at all positions tested (Fig. 3c) . These findings demonstrate that TIP60-dependent acetylation of H4K16 reduces the interaction between 53BP1 and its cognate recognition element H4K20me2 when present on the same H4 peptide.
H4K16 interacts with the second 53BP1 Tudor domain
To understand the structural basis underlying the observation that H4ac reduces the interaction of 53BP1 with H4K20me2 peptides, we determined the three-dimensional structure of 53BP1-Tudor in complex with an H4K20me2 peptide encompassing residues 14-27 using NMR spectroscopy with 13 C/ 15 N labeling of 53BP1-Tudor and H4K20me2 containing a methyllysine analog (H4K C 20me2) 35 ( Fig. 4a-c, Table 1 and Supplementary Figs. 5-7) . Previous crystallographic studies revealed the structure of this complex 5 , but the electron density of the H4K20me2 peptide was discernible only for the H4 amino acids Arg19 and K20me2, thus prompting an investigation of the structure using NMR. To calculate the structure of the 53BP1-Tudor-H4K20me2 complex, we used 100 intermolecular nuclear Overhauser enhancement signals (NOEs) involving the H4 amino acids Gly14, Ala15, Lys16, Arg17, His18, Arg19, Val21, Leu22 and Arg23 ( Table 1 and Supplementary Table 1 ). As a result of exchange broadening, which led to the disappearance of the NMR signals of K20me2 and K C 20me2 because of conformational exchange, no intermolecular NOEs involving K20me2 or K C 20me2 could be detected, and therefore no intermolecular distances could be determined for this amino acid. Therefore, we included 26 distance restraints derived from the crystal structure of the 53BP1-Tudor-H4K20me2 complex 5 in the calculations to position the side chain of K20me2 in the aromatic binding cage of 53BP1. The assumption here was that one of the K20me2 conformations in exchange in the binding cage corresponds to the conformation detected in the crystal structure. Although signal broadening is a clear indication of conformational exchange of K20me2, the NMR data also strongly suggest that K20me2 or K C 20me2 occupies an aromatic binding cage in 53BP1-Tudor, as seen in the previously determined crystal structure of 53BP1-Tudor-H4K20me2 (ref. 5). In the 1 H-15 N heteronuclear single quantum coherence (HSQC) spectrum of 53BP1-Tudor, the backbone HN resonances of Tyr1502, Phe1519, Asp1521 and Tyr1523 and the side chain indole HN resonance of Trp1495 showed pronounced changes in chemical shift after addition of the H4K20me2 or H4K C 20me2 peptides. These five 53BP1 residues form the binding cage. Notably, there was a 0.8-p.p.m. downfield shift of the Trp1495 indole HN proton (Fig. 4a,c and Supplementary Fig. 6a ), which is fully consistent with the establishment of a cation-π interaction between the indole ring of Trp1495 and the dimethylammonium group of K20me2. This shift was markedly reduced when we titrated 53BP1-Tudor with a nonmethylated H4K20 peptide (Supplementary Fig. 6b ). Also in strong agreement with a cation-π interaction between Trp1495 and K20me2 positioning K20me2 in the aromatic cage, we detected large downfield shifts in the 1 H-13 C HSQC spectrum for side chain resonances of Trp1495 after addition of H4K20me2 ( Supplementary  Fig. 6c ). Further evidence for conformational exchange in the vicinity of K20me2 is the presence of multiple signals for the side chain 1 H-13 C resonances of Leu22 in the 13 C-labeled H4K20 C me2 peptide after titration with 53BP1-Tudor (Supplementary Fig. 6d ).
In the NMR structure, the central H4K20me2 peptide region adopts a looping conformation. H4K16 is positioned in the immediate vicinity of 53BP1 Glu1551, indicating a direct salt bridge between the positively charged H4K16 and the negatively charged Glu1551 (Fig. 4a,b and Supplementary Fig. 7a ). Acetylation of H4K16 would eliminate the positive charge from Lys16, disrupting the electrostatic interaction. H4R17 occupies a pocket at the interface between the two Tudor domains and also forms a charged interaction with Glu1551 (Supplementary Fig. 7a) . A stretch of acidic amino acids (Glu1549, Asp1550 and Glu1551) in the second 53BP1 Tudor domain is completely conserved across all vertebrate species (Fig. 4d) , suggesting the general importance of this charge-charge interaction for regulatory binding to H4K20me2. Although acetylation would eliminate the salt bridge between H4K16 and the 53BP1 acidic patch, it is important to note that some interaction may be maintained between H4K16ac and the 53BP1 Tudor domain, thus accounting for the reduced, albeit not absent, association in pulldown experiments (Fig. 3b) . Consistent with this assertion, the side chains of H4 Lys16 and 53BP1 Tyr1552 are in contact in the NMR structure, as we detected several NOEs between these two residues (Supplementary Figs. 6e and 7a and  Supplementary Table 1) . The interaction between Tyr1552 and Lys16 orients Lys16 toward Glu1551. We introduced mutations into the H4K C 20me2 peptide to validate the structure of the complex (Supplementary Fig. 7b ).
53BP1 impedes BRCA1 DSB localization in TIP60-deficient cells
The results described above demonstrate that acetylation has opposing effects on BRCA1 and 53BP1 at DSBs and modulates a competition between them for accumulation at sites of DNA damage. npg a r t i c l e s In support of this idea, we found approximately two-fold elevated 53BP1 levels at the DSB reporter locus after BRCA1 knockdown and four-fold increased BRCA1 accumulation after 53BP1 knockdown (Fig. 5a-c) . Moreover, BRCA1 IRIF was largely restored in cells with combined TIP60 and 53BP1 knockdown ( Fig. 5d-f) . These results strongly suggest that 53BP1 inhibits BRCA1 DSB access in the context of hypoacetylated chromatin.
Acetylation alleviates a 53BP1-dependent block of DSB repair
Homologous recombination requires DNA end resection and Rad51 nucleofilament formation on 3′ overhangs to initiate strand invasion into a sister chromatid. BRCA1 mutation results in diminished homologous recombination and Rad51 DSB accumulation, which has been associated with reduced end resection 1,2,36-38 . 53BP1 nullizygosity restores end resection, Rad51 IRIF and homologous recombination, a r t i c l e s in addition to restoring viability through embryogenesis and resistance to PARPi in BRCA1-mutant cells 1,2 . These observations support a prediction that deficiency in either TIP60 or RVB1 would diminish end resection and Rad51 nucleofilament formation and that HDACi or co-depletion of 53BP1 would at least partially rescue these functions. Consistent with this assertion, knockdown of RVB1 or TIP60 strongly reduced RPA and Rad51 accumulation at the LacI-FokI reporter, which was restored by TSA treatment (Fig. 6a-c) . Moreover, TIP60 knockdown reduced homology-directed DNA repair (HDR) at an I-SceI nuclease-induced DSB to a similar extent as did BRCA1 knockdown (Fig. 6d) . Dual knockdown of BRCA1 and 53BP1 restored HDR, as previously described 1, 2 . Similarly, 53BP1 knockdown rescued HDR in TIP60-deficient cells, consistent with restoration of BRCA1 DSB repair function (Fig. 6d) .
53BP1 promotes sensitivity to PARPi during TIP60 deficiency BRCA1 mutation confers hypersensitivity to the PARPi olaparib, which is reversed by 53BP1 nullizygosity 39, 40 . To determine whether an equivalent genetic interaction exists between 53BP1 and TIP60, we transfected 53BP1 +/+ and 53BP1 −/− mouse embryonic fibroblasts with siRNA to TIP60 and then exposed them to olaparib. Nullizygosity for 53BP1 strongly mitigated the impact of TIP60 knockdown on radial chromosome formation ( Fig. 7a) , showing reductions similar to those reported for cells harboring mutations in both BRCA1 and 53BP1 (ref. 1). Moreover, TIP60 deficiency resulted in hypersensitivity to olaparib that was reversed by accompanying 53BP1 knockdown (Fig. 7b) , demonstrating that excessive 53BP1 activity can mediate hypersensitivity to PARPi in the context of hypoacetylation. Collectively these findings support a new mechanism in which sequential histone modifications encompassing H4K16ac in cis to Lys20 methylation facilitates segregation of BRCA1 and 53BP1 into distinct chromatin territories to influence DSB repair mechanism (Fig. 7c) .
DISCUSSION
BRCA1 and 53BP1 are chromatin-associated DNA damage-response proteins with dichotomous roles in dictating DNA repair mechanism choice. BRCA1 is firmly implicated in promoting homologous recombination, whereas 53BP1 is required for certain types of NHEJ exemplified by class-switch recombination at immunoglobulin loci and fusions of deprotected telomeres [41] [42] [43] . Genetic evidence in mice reveals that a major component of BRCA1 function in promoting homologous recombination, genomic stability and tumor suppression is to counterbalance 53BP1 DSB chromatin activities 1,2 . BRCA1 deficiency results in 53BP1-dependent illegitimate end joining, genomic instability and cancer susceptibility. We establish that oppositional TIP60 acetylation and class I and II HDAC-mediated deacetylation are essential determinants of a competition between BRCA1 and 53BP1 for DSB chromatin association. Hypoacetylation caused by TIP60 deficiency mimicked BRCA1 mutation, resulting in reduced BRCA1 and Rad51 DSB localization and enhanced radial chromosome formation and sensitivity to PARPi. Each of these sequela was reverted by concomitant 53BP1 deficiency, suggesting that inappropriate accumulation of 53BP1 at DSB chromatin is a common event that is responsible for genomic instability in the context of either BRCA1 mutation or hypoacetylation caused by TIP60 deficiency.
Our data support a model in which acetylation of H4K16 has a central role in determining the balance of BRCA1 and 53BP1 at DSB chromatin by reducing, albeit not eliminating, the binding affinity of the 53BP1 Tudor domain for H4K20me2 when present on the same H4 tail. Thus, sequential histone modifications act in a combinatorial manner to limit 53BP1 DSB chromatin occupancy, thereby promoting BRCA1 DSB localization and HDR. The solution structure of H4K20me2 peptides in association with the 53BP1 Tudor domains reveals a direct charge-charge interaction between H4K16 and the 53BP1 Tudor domain residue Glu1551, which belongs to a conserved patch of acidic residues. This information was not available from previous crystallographic studies involving the 53BP1 Tudor domains and an H4K20me2 peptide because of a lack of discernible electron density of H4 residues other than H4K20me2 and Arg19 (ref. 5). The salt bridge interaction between H4K16 and 53BP1 Glu1551 reveals a potential common mode of regulation with respect to H4 binding proteins. Notably, H4K16 interacts with an acidic patch present at the H2A-H2B interface in nucleosomes, and H4K16 also forms a salt bridge with a conserved acidic residue present in the H4K20me2 binding domain of Orc1 (refs. 44,45) . Acetylation of H4K16 would eliminate the charged interaction with the 53BP1 Tudor domain residue Glu1551, as well as with each of these other interacting partners.
Although biochemical and structural data indicate that acetylation sequential to H4K20me2 regulates the balance between 53BP1 and BRCA1 at DSBs (Fig. 7c) , other TIP60-dependent mechanisms may also contribute, such as the involvement of acetyl-lysine binding proteins and acetylation on additional TIP60 substrate besides H4K16. The solution structure of 53BP1 with an H4K20me2 peptide predicts that association of an H4K16ac binding protein would further disrupt this interaction. It will therefore be of interest to determine whether (c) Model depicting that TIP60-dependent acetylation limits 53BP1 binding to H4K20Me2 when present on the same histone H4 tail. TIP60 deficiency would result in hypoacetylated H4K16 and a 53BP1-dependent block of BRCA1 DSB chromatin association. npg a r t i c l e s a putative TIP60-regulated H4K16ac binding protein is present at DSBs and whether it exerts similar control of BRCA1 and 53BP1 DSB localization. In addition, incorporation of synthetic H4K16ac into nucleosomes prevents compaction of chromatin into 30-nm fibers in vitro 46 . The contribution of changes in higher-order chromatin structure to BRCA1 and 53BP1 DSB chromatin occupancy caused by H4K16ac may also warrant examination in future studies.
Both TIP60 and HDACs have been reported to localize to DSBs, suggesting that a dynamic process of acetylation and deacetylation affects DSB repair mechanism outcome. Consistent with our findings, HDAC1 and HDAC2 are required for efficient NHEJ, a 53BP1dependent process 47 . Deacetylation occurred at the early phases of the DNA damage response, with H4K16 acetylation accumulating over several hours after the initial wave of deacetylation. The kinetics of deacetylation and acetylation therefore closely mirror the timing of 53BP1 and BRCA1 foci formation. 53BP1 IRIF occur within minutes of DNA damage induction, whereas BRCA1 IRIF accumulate over hours, despite both depending on RNF168-dependent ubiquitylation. In addition, BRCA1 and 53BP1 show nonoverlapping localization at IRIF by super-resolution fluorescence imaging 48 . This difference is suggestive of additional events contributing to the later onset of BRCA1 IRIF. Our results are consistent with TIP60-dependent acetylation as being an important determinant and help explain the divergent DSB localization properties of BRCA1 and 53BP1 despite their common reliance on γ-H2AX, MDC1, RNF8 and RNF168.
Hereditary breast and ovarian cancer susceptibility is a consequence of germline, heterozygous mutations in the BRCA1 and BRCA2 genes. Patient with such cancers are heterozygous, and their tumors generally have loss of the wild-type BRCA allele, thus creating tumor-specific homologous recombination deficiency. This feature of a BRCA-null tumor in the context of a heterozygous patient inspired the development of PARPi as a synthetic lethal strategy to exploit tumor-specific homologous recombination deficiency 39, 40, 49 . The data presented here suggest that consideration of histone acetylation levels may be informative in predicting responses to PARPi and other DNA-damaging anticancer therapies. Importantly, histone H4K16 acetylation is frequently reduced in cancers 50 . Moreover, TIP60 is a haploinsufficient tumor suppressor in mice, and TIP60 mutations as well as reduced TIP60 expression have been reported in a broad range of cancer types, including breast cancer 51 . Our findings extend the concept that chromatin modifications have a crucial role in establishing the balance between repair proteins at sites of DSBs and suggest that consideration of either TIP60 status or histone acetylation levels may be informative in predicting responses to anticancer therapy.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The atomic coordinates for the NMR structure of 53BP1-Tudor-H4K20me2 have been deposited in the Protein Data Bank with accession code 2LVM. The associated NMR chemical shifts have been deposited in the Biological Magnetic Resonance Bank with accession code 18579.
